Although HLHS can be treated, it’s a condition that will never be cured.
The infant may need to undergo a series of treatment sessions throughout his life and will more than likely live with long-term medical complications.
In some instances, children with HLHS may need a complete heart transplant. In other instances, surgeons may need to perform open heart surgery to get the damaged part of the heart working again and to ensure blood is flowing properly. The plaintiff’s son is still alive today, but in many cases, babies born with HLHS die within hours to days after birth.
Unfortunately, the plaintiff’s Zofran lawsuit is not the only incident in which babies were born with severe heart defects after being exposed to the medication. In fact, there are at least a dozen pending Zofran lawsuits that state that infants were born with numerous kinds of congenital heart defects after pregnant women were prescribed Zofran for morning sickness.
If Zofran causes such devastating effects in infants, why is it still being prescribed to pregnant women? The answer more than likely comes down to GlaxoSmithKline seeing an extremely profitable market for the medication with pregnant women. In fact, the drug manufacturer is accused of offering kickbacks to physicians who prescribe Zofran for off-label morning sickness.
If you’re currently pregnant and taking Zofran, it’s important to understand the risks being posed on your infant. Unfortunately, the majority of women who are prescribed Zofran are never told how harmful it can be on their growing babies. For many women, it’s already too late. However, as the public becomes more and more aware of the dangers of the medication and Zofran lawsuits, the better the chance women have in the future of not taking Zofran while pregnant.
This blog will include a range of reports and opinion pieces covering many issues. It will be YOUR Voice.